NCT00456495 2017-07-21
Effect of Ranibizumab on Malignant Conjunctival Neoplasia
The New York Eye Cancer Center
Phase 1 Completed
Clinical Trials
7 trialsNCT00089765 2017-07-02
Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00680225 2017-04-12
Lucentis as an Adjuvant Therapy With TTT-ICG Based in Choroidal Melanoma
New England Retina Associates
Phase 3 Completed
NCT00765921 2016-12-02
Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma
Massachusetts Eye and Ear Infirmary
Phase 1 Completed
NCT01251978 2016-10-19
Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)
New England Retina Associates
Phase 2 Completed
NCT00657202 2016-07-07
Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1
Massachusetts General Hospital
Phase EARLY_PHASE1 Completed
NCT00750399 2012-04-26
Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma
The New York Eye Cancer Center
Phase 1 Completed